Effective IP Mechanisms for Bringing Biopharmaceuticals to Market 

Haian Chen - Haiyan Chen is senior patent counsel at GlaxoSmithKline R&D China.  Ms. Chen works on a variety of IP issues and her responsibilities include providing IP advices and opinions, developing and maintaining patent portfolios, developing IP strategy, and conducting IP due diligence.  Prior to joining GSK in 2009, Ms. Chen was a patent attorney at Fitzpatrick Cella in New York. Ms. Chen received her J.D. from Georgetown University and her Ph.D. in Biochemistry from Harvard University.

Jeffrey D. Hsi - Jeffrey's practice is devoted to corporate counseling, formation and execution of intellectual property strategy, and patent prosecution and opinion work in the areas of chemistry pharmaceuticals, biotechnology, agriculture, nutraceuticals, polymers, diagnostics, and medical devices.

Jeffrey's clients include multinational chemical and pharmaceutical companies, emerging biopharmaceutical companies, and academic and governmental research institutions throughout the world.

Jeffrey also served as Chair of the Firm's Intellectual Property Department for the past five years and serves on the Firm's Boston Office Teamwork and Diversity Strategic Committee.

Jeffrey has considerable experience in patent prosecution matters. He has prepared and prosecuted patent applications relating to pharmaceuticals (both approved and candidates in clinical trials), drug design/discovery technologies, nutraceuticals, medical diagnostics and biotechnology. Jeffrey also is experienced in specialty chemical and polymer technologies, medical devices, food and agricultural technologies and business methods.

Jeffrey also has experience in transactional matters including negotiation and establishment of licensing and R&D collaboration agreements, manufacturing and supply agreements, due diligence studies, venture capital funding, merger and acquisition, and technology acquisitions.

As in-house counsel to a biopharmaceutical start-up company, Jeffrey established and guided the company's patent law department, including formation of worldwide corporate intellectual property strategy and internal intellectual property policies.

Jeffrey also advised on aspects of corporate and business development activities. The start-up was ultimately acquired by a major U.S. biotechnology company.

Jeffrey is an invited speaker internationally on various intellectual property issues and has lectured at the Harvard Extension School and at MIT Sloan School of Management. Jeffrey is a co-author of written materials and lectured for the "Biotechnology: Patents, Licensing & FDA Practice" course for the Patent Resources Group.

Jeffrey is a co-inventor on two U.S. Patents and co-author of numerous scientific publications and presentations.

Jonathan Z. Yuan - Jonathan is a managing partner for US & European IP Practice at Shangcheng & Partners, an intellectual property law firm located in Beijing with a branch office in Shanghai. Jonathan is a U.S. patent attorney registered to practice before the United States Patent and Trademark Office. He is also an attorney at law admitted in New York and Connecticut. Jonathan's practice focuses on patent counseling, strategies, search and analysis, opinion, procurement, patent litigation/ITC 337 actions and licensing in technology fields including life sciences, pharmaceuticals, material sciences, medical devices and electronics. He counsels various clients, most of which are based in US and Europe, ranging from multinational pharmaceutical companies to start-ups and academic institutions

Jonathan obtained his B.S. in biology from Peking University, China. He was later trained in a master of medicine program at Peking Union Medical College in Beijing and a Ph.D. program on cell and molecular biology in City University of New York. He earned his master’s degree in biology from City College of New York and his J.D. from St. John’s University School of Law in New York. Prior to pursuing his legal career, Jonathan conducted research in molecular and developmental biology at Cold Spring Harbor Laboratory.

Before joining Shangcheng, Jonathan was a partner at one the largest IP law firms in China as well as the head of the firm’s Shanghai office. Before that, Jonathan was an attorney with a large international law firm based in US and a representative/visiting attorney at the firm’s Shanghai and Beijing offices. Jonathan started his legal career at a well-known IP boutique in New York.

Jonathan is frequently invited to speak in international IP conferences and was interviewed by major media in US and China on various IP issues. He was one of the key organizers behind several high-profile IP forums in China. Jonathan is an author/a co-author of numerous scientific and legal publications, including an article featured on cover of China Law and Practice (2010), Chapter of “Patent Law” in the book Doing Business in China (2010), and a research article featured on cover of Cell (1998) as well as other peer-reviewed articles on journals Development, Proc Natl Acad Sci USA, and Genes & Development. Jonathan is a co-inventor on a PCT application filed in the US.

Jonathan is a member of AIPLA, INTA and AUTM.